Literature DB >> 16911473

Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.

Anja M Geerts1, An S De Vriese, Eline Vanheule, Hans Van Vlierberghe, Siska Mortier, Kin-Jip Cheung, Pieter Demetter, Norbert Lameire, Martine De Vos, Isabelle Colle.   

Abstract

BACKGROUND: In vivo evidence for angiogenesis in the splanchnic vasodilation in portal hypertension (PHT) and cirrhosis is lacking. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) are mediators of angiogenesis. The present study visualises in vivo structural changes (angiogenesis and vascular hyperpermeability) and examines the presence of VEGF and eNOS in the mesenteric microvasculature of animal models of PHT with and without cirrhosis.
METHODS: Portal hypertension was induced by partial portal vein ligation (PPVL) and cirrhosis was induced by common bile duct ligation (CBDL) in rats. The mesenteric microcirculation was examined by intravital microscopy. Expression of VEGF, eNOS and CD31 in mesenteric tissue were studied by immunohistochemistry.
RESULTS: An increased mesenteric angiogenesis was observed in PPVL and CBDL rats compared with Sham-operated and control rats, as shown by intravital microscopy and CD 31 staining. VEGF and eNOS expression was higher in CBDL and PPVL rats compared with control groups and correlated positively with vascular density. Macromolecular leakage was increased in cirrhotic rats compared with control and PPVL rats.
CONCLUSION: Our study provides in vivo evidence of an increased angiogenesis in the mesenteric microvasculature of animal models of PHT and cirrhosis. Increased VEGF and eNOS expression in the mesentery of PPVL and CBDL rats may suggest their contribution. Microvascular permeability in the mesenteric vessels was only increased in cirrhotic rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911473     DOI: 10.1111/j.1478-3231.2006.01308.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  18 in total

Review 1.  Pathophysiology of portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Clin Liver Dis       Date:  2014-02-25       Impact factor: 6.126

2.  Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.

Authors:  Femke Heindryckx; Koen Mertens; Nicolas Charette; Bert Vandeghinste; Christophe Casteleyn; Christophe Van Steenkiste; Dominique Slaets; Louis Libbrecht; Steven Staelens; Peter Starkel; Anja Geerts; Isabelle Colle; Hans Van Vlierberghe
Journal:  Mol Cancer       Date:  2010-08-20       Impact factor: 27.401

3.  Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment.

Authors:  Mohamed Ahmed Abdelmoaty; Ahmed Mohamed Bogdady; Mervat Mohamed Attia; Nayel Abdelhamed Zaky
Journal:  Indian J Clin Biochem       Date:  2009-12-30

Review 4.  Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.

Authors:  Yasuko Iwakiri; Vijay Shah; Don C Rockey
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

5.  PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.

Authors:  Yuqing Liu; Eric Lik Hang Lui; Scott L Friedman; Lei Li; Tao Ye; Yongjun Chen; Ronnie T Poon; Jana Wo; Tsz Wai Kok; Sheung Tat Fan
Journal:  Lab Invest       Date:  2008-12-29       Impact factor: 5.662

6.  N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.

Authors:  Francielli Licks; Renata Minuzzo Hartmann; Camila Marques; Elizângela Schemitt; Josieli Raskopf Colares; Mariana do Couto Soares; Juliana Reys; Camila Fisher; Juliana da Silva; Norma Possa Marroni
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 7.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

8.  Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling.

Authors:  Tony E Walshe; Vandana S Dole; Arindel S R Maharaj; Ian S Patten; Denisa D Wagner; Patricia A D'Amore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-05-21       Impact factor: 8.311

9.  Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

Authors:  Xiaofeng Sun; Andrés Cárdenas; Yan Wu; Keichi Enjyoji; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-11       Impact factor: 4.052

10.  Noninvasive evaluation of portal hypertension: emerging tools and techniques.

Authors:  V K Snowdon; N Guha; J A Fallowfield
Journal:  Int J Hepatol       Date:  2012-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.